# Yale Cancer Center
**Type:** Institutions
**Canonical URL:** https://picoportal.org/library/institutions/yale-cancer-center/
## Facts
| Field | Value |
| --- | --- |
| Avg h-index | 83.5 |
| Citations | 1,376,819 |
| City | New Haven |
| Country | US |
| Description | Yale Cancer Center is a research organisation in New Haven, US. OpenAlex records 12,409 works and 1,376,819 citations for it. 1,862 researchers list it as their most recent affiliation. |
| Homepage | https://www.yalecancercenter.org |
| OpenAlex ID | https://openalex.org/I2802730090 |
| Researchers | 1,862 |
| ROR ID | https://ror.org/03j7sze86 |
| Type | facility |
| Wikidata ID | https://www.wikidata.org/wiki/Q8047359 |
| Works | 12,409 |
## University papers
Showing 12 of 143.
- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://picoportal.org/library/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://picoportal.org/library/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [Compendium of Physical Activities: an update of activity codes and MET intensities](https://picoportal.org/library/papers/compendium-of-physical-activities-an-update-of-activity-codes-and-met/)
- [Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial](https://picoportal.org/library/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/)
- [Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer](https://picoportal.org/library/papers/pembrolizumab-for-the-treatment-of-non-small-cell-lung-cancer/)
- [EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib](https://picoportal.org/library/papers/egf-receptor-gene-mutations-are-common-in-lung-cancers-from-never-smokers-and/)
- [EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib](https://picoportal.org/library/papers/i-egfr-i-mutation-and-resistance-of-non-small-cell-lung-cancer-to-gefitinib/)
- [Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain](https://picoportal.org/library/papers/acquired-resistance-of-lung-adenocarcinomas-to-gefitinib-or-erlotinib-is/)
- [Pembrolizumab for Early Triple-Negative Breast Cancer](https://picoportal.org/library/papers/pembrolizumab-for-early-triple-negative-breast-cancer/)
- [The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014](https://picoportal.org/library/papers/the-evaluation-of-tumor-infiltrating-lymphocytes-tils-in-breast-cancer/)
- [Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates](https://picoportal.org/library/papers/phase-i-study-of-single-agent-anti-programmed-death-1-mdx-1106-in-refractory/)
- [Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer](https://picoportal.org/library/papers/response-to-neoadjuvant-therapy-and-long-term-survival-in-patients-with-triple/)
## University researchers
Showing 15 of 30.
- [Eric P. Winer](https://picoportal.org/library/researchers/eric-p-winer/)
- [Spencer L James](https://picoportal.org/library/researchers/spencer-l-james/)
- [Charles S. Fuchs](https://picoportal.org/library/researchers/charles-s-fuchs/)
- [Lieping Chen](https://picoportal.org/library/researchers/lieping-chen/)
- [Roy S. Herbst](https://picoportal.org/library/researchers/roy-s-herbst/)
- [Roel G.W. Verhaak](https://picoportal.org/library/researchers/roel-g-w-verhaak/)
- [David L. Rimm](https://picoportal.org/library/researchers/david-l-rimm/)
- [Lajos Pusztai](https://picoportal.org/library/researchers/lajos-pusztai/)
- [Mario Sznol](https://picoportal.org/library/researchers/mario-sznol/)
- [Ian E. Krop](https://picoportal.org/library/researchers/ian-e-krop/)
- [Nenad Šestan](https://picoportal.org/library/researchers/nenad-sestan/)
- [Marcus Bosenberg](https://picoportal.org/library/researchers/marcus-bosenberg/)
- [A Kahn](https://picoportal.org/library/researchers/a-kahn/)
- [Patricia LoRusso](https://picoportal.org/library/researchers/patricia-lorusso/)
- [Mark A. Lemmon](https://picoportal.org/library/researchers/mark-a-lemmon/)
## University top topics
Showing 8 of 25.
- [Cancer Immunotherapy and Biomarkers](https://picoportal.org/library/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://picoportal.org/library/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://picoportal.org/library/topics/cancer-genomics-and-diagnostics/)
- [Acute Myeloid Leukemia Research](https://picoportal.org/library/topics/acute-myeloid-leukemia-research/)
- [Breast Cancer Treatment Studies](https://picoportal.org/library/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://picoportal.org/library/topics/her2-egfr-in-cancer-research/)
- [CAR-T cell therapy research](https://picoportal.org/library/topics/car-t-cell-therapy-research/)
- [Colorectal Cancer Treatments and Studies](https://picoportal.org/library/topics/colorectal-cancer-treatments-and-studies/)
## University topics
- [T-cell and B-cell Immunology](https://picoportal.org/library/topics/t-cell-and-b-cell-immunology-2/)
- [Breast Cancer Treatment Studies](https://picoportal.org/library/topics/breast-cancer-treatment-studies-2/)
- [Cancer Genomics and Diagnostics](https://picoportal.org/library/topics/cancer-genomics-and-diagnostics-2/)
---
Source: PICO Portal — public research metadata, principally OpenAlex. See https://picoportal.org/library/sources/ for provenance and https://picoportal.org/library/methodology/ for what these figures mean.